Bruno Gander

5.9k total citations
75 papers, 4.9k citations indexed

About

Bruno Gander is a scholar working on Immunology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Bruno Gander has authored 75 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 26 papers in Molecular Biology and 23 papers in Pharmaceutical Science. Recurrent topics in Bruno Gander's work include Immunotherapy and Immune Responses (27 papers), Advanced Drug Delivery Systems (19 papers) and RNA Interference and Gene Delivery (12 papers). Bruno Gander is often cited by papers focused on Immunotherapy and Immune Responses (27 papers), Advanced Drug Delivery Systems (19 papers) and RNA Interference and Gene Delivery (12 papers). Bruno Gander collaborates with scholars based in Switzerland, Germany and United Kingdom. Bruno Gander's co-authors include Hans P. Merkle, Srinivas Madduri, Pål Johansen, Michaël Papaloïzos, Marcus Groettrup, Lorenz Meinel, Vera Luginbuehl, Giampietro Corradin, R Audran and Stefan Fischer and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Biomaterials.

In The Last Decade

Bruno Gander

75 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Gander Switzerland 43 1.6k 1.5k 1.3k 1.2k 1.0k 75 4.9k
Bernard Verrier France 48 3.3k 2.1× 2.6k 1.8× 691 0.5× 794 0.7× 529 0.5× 228 8.0k
Krishnendu Roy United States 43 3.1k 2.0× 1.2k 0.9× 957 0.7× 2.0k 1.7× 2.6k 2.6× 140 7.8k
Susan Gibbs Netherlands 51 1.5k 1.0× 1.0k 0.7× 481 0.4× 513 0.4× 1.0k 1.0× 189 7.1k
Moon Suk Kim South Korea 50 1.3k 0.9× 628 0.4× 697 0.5× 2.8k 2.4× 2.4k 2.4× 233 7.1k
Alejandro Sánchez Spain 33 2.1k 1.3× 529 0.4× 2.3k 1.8× 1.5k 1.3× 606 0.6× 63 4.9k
Steven R. Little United States 43 2.2k 1.4× 845 0.6× 587 0.5× 1.5k 1.3× 1.3k 1.2× 129 5.7k
Daniel G. Anderson United States 43 3.6k 2.3× 609 0.4× 646 0.5× 977 0.8× 1.7k 1.7× 71 6.9k
Tao Wan China 40 2.5k 1.6× 1.0k 0.7× 508 0.4× 604 0.5× 1.0k 1.0× 133 5.3k
Guopu Chen China 45 736 0.5× 255 0.2× 1.2k 0.9× 1.6k 1.4× 2.2k 2.2× 85 5.6k
Ana Jaklenec United States 25 1.8k 1.1× 779 0.5× 598 0.5× 713 0.6× 1.2k 1.1× 52 3.9k

Countries citing papers authored by Bruno Gander

Since Specialization
Citations

This map shows the geographic impact of Bruno Gander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Gander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Gander more than expected).

Fields of papers citing papers by Bruno Gander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Gander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Gander. The network helps show where Bruno Gander may publish in the future.

Co-authorship network of co-authors of Bruno Gander

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Gander. A scholar is included among the top collaborators of Bruno Gander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Gander. Bruno Gander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lendvai, Ádám Z., et al.. (2024). IGF-1 induces sex-specific oxidative damage and mortality in a songbird. Oecologia. 205(3-4). 561–570. 1 indexed citations
2.
Koerner, Julia, Dennis J. Horvath, Bruno Gander, et al.. (2021). PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy. Nature Communications. 12(1). 2935–2935. 125 indexed citations
3.
Lendvai, Ádám Z., et al.. (2021). Effects of experimental increase in insulin-like growth factor 1 on feather growth rate, moult intensity and feather quality in a passerine bird. Journal of Experimental Biology. 224(14). 15 indexed citations
4.
Leroux, Jean‐Christophe, et al.. (2021). Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses. Advanced NanoBiomed Research. 2(4). 10 indexed citations
5.
Gander, Bruno, et al.. (2013). Nerve conduit scaffolds for discrete delivery of two neurotrophic factors. European Journal of Pharmaceutics and Biopharmaceutics. 85(1). 139–142. 36 indexed citations
6.
Mazzotti, Marco, et al.. (2013). Formulation and drying of miconazole and itraconazole nanosuspensions. International Journal of Pharmaceutics. 443(1-2). 209–220. 78 indexed citations
7.
Johansen, Pål, Deepa Mohanan, Julia M. Martínez-Gómez, Thomas M. Kündig, & Bruno Gander. (2010). Lympho-geographical concepts in vaccine delivery. Journal of Controlled Release. 148(1). 56–62. 54 indexed citations
8.
Gómez, Julia M. Martínez, Noémi Csaba, Stefan Fischer, et al.. (2008). Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. Journal of Controlled Release. 130(2). 161–167. 56 indexed citations
9.
Schlosser, Eva, Marc Mueller, Stefan Fischer, et al.. (2008). TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine. 26(13). 1626–1637. 219 indexed citations
10.
11.
Papaloïzos, Michaël, et al.. (2006). Hydrogel nerve conduits produced from alginate/chitosan complexes. Journal of Biomedical Materials Research Part A. 80A(4). 932–937. 58 indexed citations
12.
Merkle, Hans P., et al.. (2004). Ultrasonic atomisation into reduced pressure atmosphere—envisaging aseptic spray-drying for microencapsulation. Journal of Controlled Release. 95(2). 185–195. 71 indexed citations
13.
Luginbuehl, Vera, Lorenz Meinel, Hans P. Merkle, & Bruno Gander. (2004). Localized delivery of growth factors for bone repair. European Journal of Pharmaceutics and Biopharmaceutics. 58(2). 197–208. 273 indexed citations
14.
Waeckerle‐Men, Ying, Elke Scandella, Edith Uetz‐von Allmen, et al.. (2004). Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. Journal of Immunological Methods. 287(1-2). 109–124. 73 indexed citations
15.
Nielsen, Hanne Mørck, et al.. (2004). Effect of Oil-in-Water Emulsions on 5-Aminolevulinic Acid Uptake and Metabolism to PpIX in Cultured MCF-7 Cells. Pharmaceutical Research. 21(12). 2253–2260. 2 indexed citations
16.
Meinel, Lorenz, et al.. (2001). Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres. Journal of Controlled Release. 70(1-2). 193–202. 131 indexed citations
17.
Johansen, Pål, Hans P. Merkle, & Bruno Gander. (2000). Technological considerations related to the up-scaling of protein microencapsulation by spray-drying. European Journal of Pharmaceutics and Biopharmaceutics. 50(3). 413–417. 61 indexed citations
18.
Johansen, Pål, et al.. (1999). Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs. Vaccine. 18(3-4). 209–215. 56 indexed citations
19.
Audran, R, et al.. (1998). Enhanced Immunogenicity of Microencapsulated Tetanus Toxoid with Stabilizing Agents. Pharmaceutical Research. 15(7). 1111–1116. 43 indexed citations
20.
Johansen, Pål, et al.. (1996). A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation. European Journal of Pharmaceutics and Biopharmaceutics. 42(1). 16–24. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Verrier Breakdown of academic impact, for papers by Krishnendu Roy Breakdown of academic impact, for papers by Susan Gibbs Breakdown of academic impact, for papers by Moon Suk Kim Breakdown of academic impact, for papers by Alejandro Sánchez Breakdown of academic impact, for papers by Steven R. Little Breakdown of academic impact, for papers by Daniel G. Anderson Breakdown of academic impact, for papers by Tao Wan Breakdown of academic impact, for papers by Guopu Chen Breakdown of academic impact, for papers by Ana Jaklenec
Rankless by CCL
2026